Clinical

Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer

Jervoise Andreyev, Susan Davidson, Catherine Gillespie, William Allum,Edwin Swarbrick.

The number of patients with chronic gastrointestinal (GI) symptoms after cancer therapies which have a moderate or severe impact on quality of life is similar to the number diagnosed with inflammatory bowel disease annually. However, in contrast to patients with inflammatory bowel disease, most of these patients are not referred for gastroenterological assessment. Clinicians who do see these patients are often unaware of the benefits of targeted investigation (which differ from those required to exclude recurrent cancer), the range of available treatments and how the pathological processes underlying side effects of cancer treatment differ from those in benign GI disorders. This paper aims to help clinicians become aware of the problem and suggests ways in which the panoply of syndromes can be managed.

Information and resources to assist local adoption of the practice guidance on the management of acute and chronic GI problems arising as a result of treatment for cancer 

Updated October 2013

The BSG and NCSI wish to encourage and support a range of local initiatives to adopt the above guidance. This newly updated resource pack is intended to provide gastroenterology and oncology teams with advice and links to practical materials and support from Macmillan Cancer Support, to help develop a whole pathway approach to managing gastrointestinal and other effects of cancer treatments.

This resource pack now provides a link to the Optimising Radiotherapy Bowel Injury Therapy (ORBIT) study.

Contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it